Beware of steroid-induced avascular necrosis of the femoral head in the treatment of COVID-19—experience and lessons from the SARS epidemic
S Zhang, C Wang, L Shi, Q Xue - Drug design, development and …, 2021 - Taylor & Francis
The recent outbreak of coronavirus disease 2019 (COVID-19) has become a global
epidemic. Corticosteroids have been widely used in the treatment of severe acute …
epidemic. Corticosteroids have been widely used in the treatment of severe acute …
The role of cyclodextrins in COVID-19 therapy—a literature review
B Almeida, C Domingues, F Mascarenhas-Melo… - International Journal of …, 2023 - mdpi.com
Coronavirus disease-19 (COVID-19) emerged in December 2019 and quickly spread, giving
rise to a pandemic crisis. Therefore, it triggered tireless efforts to identify the mechanisms of …
rise to a pandemic crisis. Therefore, it triggered tireless efforts to identify the mechanisms of …
Comparing efficacy and safety of different doses of dexamethasone in the treatment of COVID-19: a three-arm randomized clinical trial
N Toroghi, L Abbasian, A Nourian… - Pharmacological …, 2022 - Springer
Background and objectives Corticosteroids are commonly used in the treatment of
hospitalized patients with COVID-19. The goals of the present study were to compare the …
hospitalized patients with COVID-19. The goals of the present study were to compare the …
[HTML][HTML] A comprehensive insight into current control of COVID-19: Immunogenicity, vaccination, and treatment.
Y Mohamed, YA El-Maradny, AK Saleh… - Biomedicine & …, 2022 - Elsevier
The healthy immune system eliminates pathogens and maintains tissue homeostasis
through extraordinarily complex networks with feedback systems while avoiding potentially …
through extraordinarily complex networks with feedback systems while avoiding potentially …
Immunomodulation as a potent COVID-19 pharmacotherapy: Past, present and future
DM Hertanto, BS Wiratama, H Sutanto… - Journal of …, 2021 - Taylor & Francis
In the first year of its appearance, the 2019 coronavirus disease (COVID-19) has affected
more than 150 million individuals and killed 3 million people worldwide. The pandemic has …
more than 150 million individuals and killed 3 million people worldwide. The pandemic has …
Association between glucocorticoids treatment and viral clearance delay in patients with COVID-19: a systematic review and meta-analysis
J Li, X Liao, Y Zhou, L Wang, H Yang, W Zhang… - BMC Infectious …, 2021 - Springer
Background Evidence of glucocorticoids on viral clearance delay of COVID-19 patients is
not clear. Methods In this systematic review and meta-analysis, we searched for studies on …
not clear. Methods In this systematic review and meta-analysis, we searched for studies on …
Antirheumatic Drugs against COVID-19 from the Perspective of Rheumatologists
M Kawazoe, M Kihara, T Nanki - Pharmaceuticals, 2021 - mdpi.com
Coronavirus disease 2019 (COVID-19) remains a global threat to humanity. Its pathogenesis
and different phases of disease progression are being elucidated under the pandemic …
and different phases of disease progression are being elucidated under the pandemic …
'Dynamic zero-COVID'policy and viral clearance during an omicron wave in Tianjin, China: a city-wide retrospective observational study
Y Feng, H Shao, X Gong, Z Song, Y Xie, S Qi, L Shi… - BMJ open, 2022 - bmjopen.bmj.com
Objective To report how the Chinese mainland battled its first omicron wave, which
happened in Tianjin, a metropolis with 14 million residents. We also sought to better …
happened in Tianjin, a metropolis with 14 million residents. We also sought to better …
[HTML][HTML] Comparison of efficacy of dexamethasone and methylprednisolone in improving PaO2/FiO2 ratio among COVID-19 patients
Methods A retrospective quasi-experimental study design was used to assess the
effectiveness of methylprednisolone and dexamethasone in the improvement of PaO 2/FiO 2 …
effectiveness of methylprednisolone and dexamethasone in the improvement of PaO 2/FiO 2 …
Possibility of deterioration of respiratory status when steroids precede antiviral drugs in patients with COVID-19 pneumonia: A retrospective study
Y Shionoya, T Taniguchi, H Kasai, N Sakuma, S Imai… - PLoS …, 2021 - journals.plos.org
Introduction Coronavirus disease (COVID-19) is caused by severe acute respiratory
syndrome coronavirus 2. Although most patients with COVID-19 develop asymptomatic or …
syndrome coronavirus 2. Although most patients with COVID-19 develop asymptomatic or …